Pallas Capital Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.5K | Buy |
42,319
+22,040
| +109% | +$43K | ﹤0.01% | 803 |
|
|
2025
Q1 | $35.7K | Buy |
20,279
+3,263
| +19% | +$5.74K | ﹤0.01% | 736 |
|
|
2024
Q4 | $45.3K | Buy |
17,016
+1,082
| +7% | +$2.88K | ﹤0.01% | 575 |
|
|
2024
Q3 | $36.6K | Buy |
15,934
+2,577
| +19% | +$5.93K | ﹤0.01% | 593 |
|
|
2024
Q2 | $42.5K | Buy |
13,357
+1,788
| +15% | +$5.69K | ﹤0.01% | 497 |
|
|
2024
Q1 | $42.1K | Buy |
11,569
+1,569
| +16% | +$5.71K | ﹤0.01% | 427 |
|
|
2023
Q4 | $15.1K | Sell |
10,000
-284
| -3% | -$429 | ﹤0.01% | 355 |
|
|
2023
Q3 | $10.3K | Hold |
10,284
| – | – | ﹤0.01% | 344 |
|
|
2023
Q2 | $17.5K | Buy |
10,284
+284
| +3% | +$483 | ﹤0.01% | 258 |
|
|
2023
Q1 | $17.5K | Hold |
10,000
| – | – | ﹤0.01% | 268 |
|
|
2022
Q4 | $23.6K | Hold |
10,000
| – | – | ﹤0.01% | 266 |
|
|
2022
Q3 | $21K | Hold |
10,000
| – | – | ﹤0.01% | 250 |
|
|
2022
Q2 | $31K | Hold |
10,000
| – | – | ﹤0.01% | 224 |
|
|
2022
Q1 | $55K | Buy |
+10,000
| New | +$55K | 0.01% | 231 |
|